-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Drugs Made In America Acquisition Corp. quarterly Operating Income (Loss) history and growth rate from Q2 2024 to Q2 2025.
- Drugs Made In America Acquisition Corp. Operating Income (Loss) for the quarter ending June 30, 2025 was -$132K, a 140% decline year-over-year.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)